3 US Stocks Estimated To Be Trading At Discounts Up To 40.9%
In This Article:
As the U.S. stock market experiences fluctuations with major indices like the Dow Jones and Nasdaq showing mixed movements, investors are keenly observing sectors such as technology for potential opportunities amid ongoing economic developments. In this environment, identifying undervalued stocks can be crucial, as these investments may offer significant potential when trading at discounts compared to their intrinsic value.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Clear Secure (NYSE:YOU) | $26.98 | $53.27 | 49.4% |
| UMB Financial (NasdaqGS:UMBF) | $122.36 | $244.39 | 49.9% |
| Business First Bancshares (NasdaqGS:BFST) | $28.29 | $55.10 | 48.7% |
| West Bancorporation (NasdaqGS:WTBA) | $23.59 | $46.42 | 49.2% |
| Equity Bancshares (NYSE:EQBK) | $46.75 | $92.77 | 49.6% |
| U.S. Physical Therapy (NYSE:USPH) | $94.06 | $187.03 | 49.7% |
| Constellium (NYSE:CSTM) | $11.31 | $22.03 | 48.7% |
| Freshpet (NasdaqGM:FRPT) | $145.69 | $283.12 | 48.5% |
| Equifax (NYSE:EFX) | $265.29 | $529.48 | 49.9% |
| Marcus & Millichap (NYSE:MMI) | $40.82 | $81.04 | 49.6% |
Let's uncover some gems from our specialized screener.
BioLife Solutions
Overview: BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy industry globally, with a market cap of approximately $1.22 billion.
Operations: The company's revenue is primarily derived from its Biopreservation Tools segment, amounting to $146.96 million.
Estimated Discount To Fair Value: 18.3%
BioLife Solutions is trading at US$26.72, below its estimated fair value of US$32.7, suggesting it may be undervalued based on cash flows. Despite recent guidance revisions due to the SciSafe divestiture, the company reported improved quarterly results with a net loss reduction from US$29.13 million to US$1.7 million year-over-year. Revenue growth is expected at 11.1% annually, surpassing the U.S market average of 9%. However, shareholder dilution remains a concern.
Alkami Technology
Overview: Alkami Technology, Inc. provides cloud-based digital banking solutions in the United States and has a market cap of approximately $3.99 billion.
Operations: The company's revenue is primarily derived from its Internet Software & Services segment, which generated $315.56 million.
Estimated Discount To Fair Value: 10.7%